Keren Jia

851 total citations
20 papers, 523 citations indexed

About

Keren Jia is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Keren Jia has authored 20 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Keren Jia's work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (2 papers). Keren Jia is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (2 papers). Keren Jia collaborates with scholars based in China, Ethiopia and United States. Keren Jia's co-authors include Yingcheng Wu, Yang Chen, Huiqun Wu, Lin Shen, Hui Shi, Cheng Zhang, Maorong Jiang, Jifang Gong, Jiajia Yuan and Qianqian Ju and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Keren Jia

19 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keren Jia China 11 299 193 134 124 99 20 523
M.M. Leblond Switzerland 10 167 0.6× 103 0.5× 233 1.7× 147 1.2× 65 0.7× 16 475
Weiwei Jin China 15 331 1.1× 207 1.1× 47 0.4× 176 1.4× 87 0.9× 46 649
Bowen Zhu China 10 174 0.6× 132 0.7× 143 1.1× 93 0.8× 104 1.1× 22 614
Fengchun Lu China 12 327 1.1× 112 0.6× 189 1.4× 145 1.2× 90 0.9× 43 588
Shozo Hojo Japan 10 335 1.1× 89 0.5× 269 2.0× 184 1.5× 80 0.8× 23 612
Jieti Wang China 15 344 1.2× 147 0.8× 318 2.4× 165 1.3× 99 1.0× 24 582
Fumitaka Arihara Japan 7 327 1.1× 95 0.5× 319 2.4× 50 0.4× 34 0.3× 13 555
Isabella C. Glitza Oliva United States 14 416 1.4× 180 0.9× 104 0.8× 143 1.2× 69 0.7× 38 593
Bernadette Reyna Asuncion United States 9 425 1.4× 301 1.6× 180 1.3× 147 1.2× 98 1.0× 16 658
Eugene Makarev United States 6 218 0.7× 83 0.4× 118 0.9× 177 1.4× 65 0.7× 6 427

Countries citing papers authored by Keren Jia

Since Specialization
Citations

This map shows the geographic impact of Keren Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Jia more than expected).

Fields of papers citing papers by Keren Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keren Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Jia. The network helps show where Keren Jia may publish in the future.

Co-authorship network of co-authors of Keren Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Keren Jia. A scholar is included among the top collaborators of Keren Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keren Jia. Keren Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xie, Yi, Haoxin Peng, Yajie Hu, et al.. (2025). Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer. BMC Medicine. 23(1). 59–59. 6 indexed citations
3.
Chen, Yang, Keren Jia, Yi Xie, et al.. (2025). The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. Journal of Hematology & Oncology. 18(1). 42–42. 10 indexed citations
4.
Jia, Keren, Chen Yang, Yi Xie, et al.. (2024). Helicobacter pylori and immunotherapy for gastrointestinal cancer. The Innovation. 5(2). 100561–100561. 33 indexed citations
5.
Peng, Haoxin, Jiajia Yuan, Xiangrong Wu, et al.. (2024). Single‐cell characterization of differentiation trajectories and drug resistance features in gastric cancer with peritoneal metastasis. Clinical and Translational Medicine. 14(10). e70054–e70054. 11 indexed citations
6.
Gao, Jing, Zhengyi Wang, Wenqing Jiang, et al.. (2023). CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation. Journal for ImmunoTherapy of Cancer. 11(6). e006704–e006704. 24 indexed citations
7.
Chen, Yang, Xi Jiao, Chang Liu, et al.. (2023). The landscape of cancer research and cancer care in China. Nature Medicine. 29(12). 3022–3032. 46 indexed citations
8.
Jia, Keren, Xiaoyi Chong, Zhongwu Li, et al.. (2023). ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts. Advanced Science. 10(24). e2300881–e2300881. 29 indexed citations
9.
Jia, Keren, Yang Chen, Yi Xie, et al.. (2023). Multidimensional immune profiling in Gastric Cancer Multiplex Immunohistochemistry Atlas from Peking University Cancer Hospital project informs PD-1/PD-L1 blockade efficacy. European Journal of Cancer. 189. 112931–112931. 4 indexed citations
10.
Qi, Changsong, Jifang Gong, Miao Zhang, et al.. (2023). Abstract 6482: CLDN18.2 expression is associated with clinicopathological features and prognosis of Chinese patients with digestive system cancers: a retrospective analysis. Cancer Research. 83(7_Supplement). 6482–6482. 1 indexed citations
11.
Jia, Keren, Yang Chen, Yu Sun, et al.. (2022). Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer. BMC Medicine. 20(1). 223–223. 59 indexed citations
12.
Chen, Yang, Keren Jia, Yu Sun, et al.. (2022). Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment. Nature Communications. 13(1). 4851–4851. 115 indexed citations
13.
Zhang, Cheng, Xiaoyi Chong, Jing Gao, et al.. (2022). Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer. Journal of Extracellular Vesicles. 11(4). e12209–e12209. 36 indexed citations
14.
Jia, Keren, et al.. (2020). Wide‑ranging analysis of survival‑related alternative splicing events in invasive breast carcinoma. Oncology Letters. 20(2). 1866–1878. 1 indexed citations
15.
Jia, Keren, Yingcheng Wu, Liyang Wang, et al.. (2019). The identification of gene signature and critical pathway associated with childhood-onset type 2 diabetes. PeerJ. 7. e6343–e6343. 6 indexed citations
16.
Jia, Keren, et al.. (2019). Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma. Frontiers in Oncology. 9. 1317–1317. 6 indexed citations
17.
Wu, Yingcheng, Qianqian Ju, Keren Jia, et al.. (2018). Correlation between sex and efficacy of immune checkpoint inhibitors (PD‐1 and CTLA‐4 inhibitors). International Journal of Cancer. 143(1). 45–51. 88 indexed citations
18.
Wu, Yingcheng, Keren Jia, Huiqun Wu, et al.. (2018). A comprehensive competitive endogenous RNA network pinpoints key molecules in diabetic retinopathy. Molecular Medicine Reports. 19(2). 851–860. 10 indexed citations
19.
Wu, Yingcheng, Hui Shi, Maorong Jiang, et al.. (2017). The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta‐analysis of efficacy and safety. International Journal of Cancer. 141(12). 2562–2570. 36 indexed citations
20.
Wu, Yingcheng, Ran Xu, Keren Jia, & Hui Shi. (2017). The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysis. PLoS ONE. 12(11). e0187902–e0187902. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.M. Leblond Breakdown of academic impact, for papers by Weiwei Jin Breakdown of academic impact, for papers by Bowen Zhu Breakdown of academic impact, for papers by Fengchun Lu Breakdown of academic impact, for papers by Shozo Hojo Breakdown of academic impact, for papers by Jieti Wang Breakdown of academic impact, for papers by Fumitaka Arihara Breakdown of academic impact, for papers by Isabella C. Glitza Oliva Breakdown of academic impact, for papers by Bernadette Reyna Asuncion Breakdown of academic impact, for papers by Eugene Makarev
Rankless by CCL
2026